Trials / Completed
CompletedNCT06811753
Impact of Robotic Surgery on Systemic Immune-inflammation Index
Impact of Robotic Surgery on Systemic Immune-inflammation Index in Gastric Cancer Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (actual)
- Sponsor
- Başakşehir Çam & Sakura City Hospital · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Robotic surgery has been gaining attention because of the physical and metabolic morbidity of the conventional open technique.The systemic immune-inflammation index(SII) has emerged as a recent and more reliable biomarker.In our single-center retrospective cohort study, the investigators investigate SII in robotic gastrectomy in order to show the advantageous effect on immune system which the investigators think as the first study in the literature.
Detailed description
Patients who underwent robotic gastrectomy between January 2021 and September 2024 were included in the study. The primary outcome was to ascertain the beneficial effects of robotic surgery in gastric cancer patients in terms of immune response. The secondary outcome was to examine the reliability of SII as a serum biomarker in comparison to previous studies on the diagnosis and postoperative follow-up of gastric cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | robotic surgery | minimally invasive surgery |
Timeline
- Start date
- 2023-12-01
- Primary completion
- 2024-12-31
- Completion
- 2025-01-01
- First posted
- 2025-02-06
- Last updated
- 2025-02-06
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT06811753. Inclusion in this directory is not an endorsement.